Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

HIV Genome-Wide Protein Associations: a Review of 30 Years of Research.

Li G, De Clercq E.

Microbiol Mol Biol Rev. 2016 Jun 29;80(3):679-731. doi: 10.1128/MMBR.00065-15. Print 2016 Sep. Review.

PMID:
27357278
2.

Requirements for nucleocapsid-mediated regulation of reverse transcription during the late steps of HIV-1 assembly.

Racine PJ, Chamontin C, de Rocquigny H, Bernacchi S, Paillart JC, Mougel M.

Sci Rep. 2016 Jun 7;6:27536. doi: 10.1038/srep27536.

3.

Natural Single-Nucleotide Variations in the HIV-1 Genomic SA1prox Region Can Alter Viral Replication Ability by Regulating Vif Expression Levels.

Nomaguchi M, Doi N, Sakai Y, Ode H, Iwatani Y, Ueno T, Matsumoto Y, Miyazaki Y, Masuda T, Adachi A.

J Virol. 2016 Apr 14;90(9):4563-78. doi: 10.1128/JVI.02939-15. Print 2016 May.

PMID:
26912631
4.

The HDAC6/APOBEC3G complex regulates HIV-1 infectiveness by inducing Vif autophagic degradation.

Valera MS, de Armas-Rillo L, Barroso-González J, Ziglio S, Batisse J, Dubois N, Marrero-Hernández S, Borel S, García-Expósito L, Biard-Piechaczyk M, Paillart JC, Valenzuela-Fernández A.

Retrovirology. 2015 Jun 24;12:53. doi: 10.1186/s12977-015-0181-5.

5.

CBFβ enhances de novo protein biosynthesis of its binding partners HIV-1 Vif and RUNX1 and potentiates the Vif-induced degradation of APOBEC3G.

Miyagi E, Kao S, Yedavalli V, Strebel K.

J Virol. 2014 May;88(9):4839-52. doi: 10.1128/JVI.03359-13. Epub 2014 Feb 12.

6.

Interactions between HIV-1 Vif and human ElonginB-ElonginC are important for CBF-β binding to Vif.

Wang X, Wang X, Zhang H, Lv M, Zuo T, Wu H, Wang J, Liu D, Wang C, Zhang J, Li X, Wu J, Yu B, Kong W, Yu X.

Retrovirology. 2013 Aug 29;10:94. doi: 10.1186/1742-4690-10-94.

7.

HIV-1 Vif: a guardian of the virus that opens up a new era in the research field of restriction factors.

Takaori-Kondo A, Shindo K.

Front Microbiol. 2013 Feb 20;4:34. doi: 10.3389/fmicb.2013.00034. eCollection 2013.

8.

An intronic G run within HIV-1 intron 2 is critical for splicing regulation of vif mRNA.

Widera M, Erkelenz S, Hillebrand F, Krikoni A, Widera D, Kaisers W, Deenen R, Gombert M, Dellen R, Pfeiffer T, Kaltschmidt B, Münk C, Bosch V, Köhrer K, Schaal H.

J Virol. 2013 Mar;87(5):2707-20. doi: 10.1128/JVI.02755-12. Epub 2012 Dec 19.

9.

Host restriction factors in retroviral infection: promises in virus-host interaction.

Zheng YH, Jeang KT, Tokunaga K.

Retrovirology. 2012 Dec 20;9:112. doi: 10.1186/1742-4690-9-112. Review.

10.

N-terminal hemagglutinin tag renders lysine-deficient APOBEC3G resistant to HIV-1 Vif-induced degradation by reduced polyubiquitination.

Wang Y, Shao Q, Yu X, Kong W, Hildreth JE, Liu B.

J Virol. 2011 May;85(9):4510-9. doi: 10.1128/JVI.01925-10. Epub 2011 Feb 23.

11.

HIV-1 viral infectivity factor interacts with TP53 to induce G2 cell cycle arrest and positively regulate viral replication.

Izumi T, Io K, Matsui M, Shirakawa K, Shinohara M, Nagai Y, Kawahara M, Kobayashi M, Kondoh H, Misawa N, Koyanagi Y, Uchiyama T, Takaori-Kondo A.

Proc Natl Acad Sci U S A. 2010 Nov 30;107(48):20798-803. doi: 10.1073/pnas.1008076107. Epub 2010 Nov 11.

12.

Features, processing states, and heterologous protein interactions in the modulation of the retroviral nucleocapsid protein function.

Mirambeau G, Lyonnais S, Gorelick RJ.

RNA Biol. 2010 Nov-Dec;7(6):724-34. Epub 2010 Nov 1. Review.

13.

Identification of dominant negative human immunodeficiency virus type 1 Vif mutants that interfere with the functional inactivation of APOBEC3G by virus-encoded Vif.

Walker RC Jr, Khan MA, Kao S, Goila-Gaur R, Miyagi E, Strebel K.

J Virol. 2010 May;84(10):5201-11. doi: 10.1128/JVI.02318-09. Epub 2010 Mar 10.

14.

Polyubiquitination of APOBEC3G is essential for its degradation by HIV-1 Vif.

Shao Q, Wang Y, Hildreth JE, Liu B.

J Virol. 2010 May;84(9):4840-4. doi: 10.1128/JVI.01911-09. Epub 2010 Feb 10.

15.

Tumultuous relationship between the human immunodeficiency virus type 1 viral infectivity factor (Vif) and the human APOBEC-3G and APOBEC-3F restriction factors.

Henriet S, Mercenne G, Bernacchi S, Paillart JC, Marquet R.

Microbiol Mol Biol Rev. 2009 Jun;73(2):211-32. doi: 10.1128/MMBR.00040-08. Review.

16.

MDM2 is a novel E3 ligase for HIV-1 Vif.

Izumi T, Takaori-Kondo A, Shirakawa K, Higashitsuji H, Itoh K, Io K, Matsui M, Iwai K, Kondoh H, Sato T, Tomonaga M, Ikeda S, Akari H, Koyanagi Y, Fujita J, Uchiyama T.

Retrovirology. 2009 Jan 7;6:1. doi: 10.1186/1742-4690-6-1.

17.
18.

APOBEC3G-independent reduction in virion infectivity during long-term HIV-1 replication in terminally differentiated macrophages.

Miyagi E, Schwartzkopff F, Plishka R, Buckler-White A, Clouse KA, Strebel K.

Virology. 2008 Sep 30;379(2):266-74. doi: 10.1016/j.virol.2008.06.033. Epub 2008 Aug 3.

19.

HIV-1 Vif, APOBEC, and intrinsic immunity.

Goila-Gaur R, Strebel K.

Retrovirology. 2008 Jun 24;5:51. doi: 10.1186/1742-4690-5-51. Review.

20.

APOBEC3G is degraded by the proteasomal pathway in a Vif-dependent manner without being polyubiquitylated.

Dang Y, Siew LM, Zheng YH.

J Biol Chem. 2008 May 9;283(19):13124-31. doi: 10.1074/jbc.M708728200. Epub 2008 Mar 6.

Items per page

Supplemental Content

Write to the Help Desk